Form 8-K - Current report:
SEC Accession No. 0001193125-24-196195
Filing Date
2024-08-08
Accepted
2024-08-07 20:44:30
Documents
16
Period of Report
2024-08-07
Items
Item 1.03: Bankruptcy or Receivership
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d859163d8k.htm   iXBRL 8-K 39877
2 EX-2.1 d859163dex21.htm EX-2.1 744068
3 EX-99.1 d859163dex991.htm EX-99.1 23196
7 GRAPHIC g859163g0806083641018.jpg GRAPHIC 2905
  Complete submission text file 0001193125-24-196195.txt   1093528

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nvta-20240807.xsd EX-101.SCH 2507
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvta-20240807_lab.xml EX-101.LAB 17202
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvta-20240807_pre.xml EX-101.PRE 10786
18 EXTRACTED XBRL INSTANCE DOCUMENT d859163d8k_htm.xml XML 3584
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

EIN.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 241185634
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)